Insights On Enterprise Solutions
-
Leveraging Single-Use Bioreactors In Bench-Scale Process Development
11/6/2025
Scaling bioprocesses requires matching critical variables to ensure consistent cell behavior and product quality. Optimize operations with efficient tools that enable more experiments per year.
-
Top 5 Cell Line Development Challenges (And How To Avoid Them)
11/6/2025
The top five common cell line development pitfalls — scalability, stability, complexity, analytics, and tech transfer — can be avoided with experienced partners and integrated, predictive strategies.
-
Optimize Your CLD With Innovative And Flexible Transposase Technology
11/6/2025
To ensure speed and stability in the manufacture of your complex biologic — mAbs, antibodies, fusion proteins, and/or antibody drug conjugates — prioritize a high-performance CLD workflow.
-
Achieve Speed, Stability, And Compliance In Cell Line Development
11/6/2025
Partnering with a CDMO that demonstrates innovative and commercially validated cell line development capabilities is essential to protecting your market position and securing investor support.
-
Build An AAV8 Platform: Lessons From A Collaborative Development Journey
11/5/2025
Explore how a modular AAV8 platform enables scalable, GMP-ready gene therapy manufacturing with reproducible outcomes, streamlined tech transfer, and adaptability across serotypes.
-
An Innovative Solution For Continuous Low pH Flow-Through Virus Inactivation
11/5/2025
Continuous biomanufacturing is reshaping how active pharmaceutical ingredients are produced. Learn how modular, automated virus inactivation solutions are helping manufacturers improve efficiency.
-
The Innovative Flow-Through Solution For Continuous Viral Inactivation
11/5/2025
Discover how a novel flow-through incubator enables precise, scalable low-pH virus inactivation with narrow residence time distribution and high log reduction value to support continuous bioprocessing.
-
A CDMO Perspective: Bioprocess Automation And Data Management
11/5/2025
Watch this video to understand data management and process automation challenges across single-use bioprocessing applications from a CDMO leader, Paul Jorjorian, VP and GM of Pharma Services at Thermo Fisher Scientific.
-
How Collaborative Preparation Drives Optimal Tech Transfer Execution
11/5/2025
Tech transfer missteps risk higher costs and lower product quality. Success hinges on a clear sponsor strategy and working with an experienced, collaborative CDMO.
-
LI-COR Biotechnology Is Now LICORbio
11/4/2025
A trusted name in biomolecular imaging unveils a new identity and renewed commitment to research. Discover how advanced tools and consistent support are helping scientists navigate the challenges of discovery.